Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five years     Commitment includes USD 100 million to advance R&D for Chagas disease, leishmaniasis, dengue, and cryptosporidiosis, and USD 150 million for next-generation antimalarials and a new formulation for babies under 5kg with malaria  […]

The post <strong>Novartis Renews Commitment to Neglected Tropical Disease and Malaria Elimination, Investing USD 250 Million over Five Years to Research and Develop New Treatments </strong> appeared first on African Media Agency.